Synthetic vaccines

Vaxxilon was founded to develop synthetic carbohydrate vaccines. These vaccines are comprised of oligosaccharides (small fragments of naturally occurring carbohydrates) attached to a carrier protein to create a semi-synthetic or the novel immune stimulator, α-galactosylceramide, to create a fully synthetic vaccine.

Pipeline

Content coming soon

Publications

Basel Area
Vaxxilon AG
Christoph Merian-Ring 11,
4153 Reinach, Switzerland
Berlin Area (Adlershof)
Vaxxilon Deutschland GmbH
Magnusstraße 11,
12489 Berlin, Germany

Copyright 2019 © Vaxxilon AG